162 related articles for article (PubMed ID: 4872761)
1. Molecular pharmacology of hallucinogens.
Johnston VS; Bradley RJ
Recent Adv Biol Psychiatry; 1968; 10():74-99. PubMed ID: 4872761
[No Abstract] [Full Text] [Related]
2. Behavioural models of psychosis.
Smythies JR; Johnston VS; Bradley RJ
Br J Psychiatry; 1969 Jan; 115(518):55-68. PubMed ID: 5781961
[No Abstract] [Full Text] [Related]
3. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
[No Abstract] [Full Text] [Related]
4. N,N-dimethyltryptamine--a possible relationship to schizophrenia?
Wyatt RJ; Gillin JC; Kaplan J; Stillman R; Mandel L; Ahn HS; VandenHeuvel WJ; Walker RW
Adv Biochem Psychopharmacol; 1974; 11(0):299-313. PubMed ID: 4602668
[No Abstract] [Full Text] [Related]
5. Biochemical abnormalities associated with schizophrenia.
Smythies JR
Br J Psychiatry; 1975; Spec No 9():41-7. PubMed ID: 1102037
[No Abstract] [Full Text] [Related]
6. The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain.
Smythies JR; Benington F; Morin RD
Int Rev Neurobiol; 1970; 12():207-33. PubMed ID: 4918144
[No Abstract] [Full Text] [Related]
7. Accumulation of tritiated 5-hydroxytryptamine in brain slices.
Ross SB; Renyl AL
Life Sci; 1967 Jul; 6(13):1407-15. PubMed ID: 4382451
[No Abstract] [Full Text] [Related]
8. Neurotransmitter basis of the behavioral effects of hallucinogens.
Rech RH; Commissaris RL
Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
[TBL] [Abstract][Full Text] [Related]
9. [Experimental psychoses induced by sleep deprivation and hallucinogens in abstaining alcoholics].
Vojtĕchovský M; Skála J; Hort V
Cesk Psychiatr; 1969 Jun; 65(3):137-49. PubMed ID: 5790305
[No Abstract] [Full Text] [Related]
10. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
Smythies JR; Beaton J; Benington F; Morin RD
Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
[No Abstract] [Full Text] [Related]
11. PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
LUDWIG AM; LEVINE J
JAMA; 1965 Jan; 191():92-6. PubMed ID: 14233246
[No Abstract] [Full Text] [Related]
12. Hallucinogens as discriminative stimuli.
Winter JC
Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
[No Abstract] [Full Text] [Related]
13. Structure-activity-relationships of certain hallucinogenic substances based on brain levels.
Vogel WH; Evans BD
Life Sci; 1977 May; 20(10):1629-35. PubMed ID: 69244
[No Abstract] [Full Text] [Related]
14. Psychotomimetic drugs: biochemistry and pharmacology.
Brimblecombe RW
Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
[No Abstract] [Full Text] [Related]
15. Glycogen phosphorylase levels in the brain of rats treated with psychotomimetic drugs and with tranquilizers.
Iriye TT; Kuna A; Simmonds FA
Biochem Pharmacol; 1965 Jul; 14(7):1169-71. PubMed ID: 5892600
[No Abstract] [Full Text] [Related]
16. The use of drug discrimination procedures to characterize hallucinogenic drug actions.
Appel JB; Cunningham KA
Psychopharmacol Bull; 1986; 22(3):959-67. PubMed ID: 3797596
[No Abstract] [Full Text] [Related]
17. A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts.
Kleinman JE; Gillin JC; Wyatt RJ
Schizophr Bull; 1977; 3(4):560-86. PubMed ID: 271353
[No Abstract] [Full Text] [Related]
18. Acute psychosis induced by psychotomimetic drug abuse. I. Clinical findings.
Bowers MB
Arch Gen Psychiatry; 1972 Oct; 27(4):437-40. PubMed ID: 5072710
[No Abstract] [Full Text] [Related]
19. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
Oelssner W
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
[No Abstract] [Full Text] [Related]
20. A relationship between the hallucinogenic activity of drugs and their electronic configuration.
Snyder SH; Merril CR
Proc Natl Acad Sci U S A; 1965 Jul; 54(1):258-66. PubMed ID: 5216361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
